Brain imaging study aims to uncover role of noradrenaline in aging and Parkinson's

NCT ID NCT07569120

First seen May 12, 2026 · Last updated May 13, 2026 · Updated 1 time

Summary

This study uses advanced PET/MRI brain scans to see how the noradrenaline system changes as people age and in Parkinson's disease. Researchers will compare healthy volunteers aged 20-80 with people who have Parkinson's. The goal is to understand how these brain changes relate to memory, movement, and other abilities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY AGING AND PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Neurologique Pierre Wertheimer - Service de Neurologie

    Bron, 69500, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.